Penicillin: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
== |
==Background== |
||
=== |
=== Nomenclature === |
||
* Broadly speaking, formulations of penicillin G are soluble and used for IV or IM administration, and penicillin V is used for oral administration but does not achieve high levels in the serum |
|||
* Directly inhibits [[Penicillin-binding protein|penicillin-binding proteins]] |
|||
{| class="wikitable" |
|||
!Formulation |
|||
!Other Names |
|||
!Comments |
|||
|- |
|||
|sodium penicillin G |
|||
|sodium benzylpenicillin |
|||
crystalline penicillin |
|||
|soluble, used for IV |
|||
|- |
|||
|procaine penicillin G |
|||
|procaine benzylpenicillin |
|||
procaine penicilli |
|||
|less soluble, used for IM |
|||
|- |
|||
|benzathine penicillin G |
|||
|DBED penicillin |
|||
|less soluble than procaine, used for IM |
|||
|- |
|||
|penicillin V |
|||
|phenoxymethylpenicillin |
|||
|used for PO, but poor absorption |
|||
|} |
|||
===Mechanism of Action=== |
|||
*Directly inhibits [[Penicillin-binding protein|penicillin-binding proteins]] |
|||
=== Spectrum of Activity === |
|||
* Generally active against Gram-positive cocci, especially [[streptococci]] but some strains of [[Staphylococcus aureus]], most [[clostridia]], [[Neisseria species]], and some [[Haemophilus influenzae]] |
|||
* Not active against aerobic Gram-negative bacilli |
|||
* Penicillin G is generally more active than penicillin V across all bacteria |
|||
=== Clinical Breakpoints === |
|||
{| class="wikitable" |
|||
! rowspan="2" |Species |
|||
! colspan="3" |Breakpoints (μg/mL) |
|||
! colspan="3" |Breakpoints (mm) |
|||
|- |
|||
!S |
|||
!I |
|||
!R |
|||
!S |
|||
!I |
|||
!R |
|||
|- |
|||
|[[Anaerobes]] except [[Bacteroides]] |
|||
|≤0.5 |
|||
|1 |
|||
|≥2 |
|||
| |
|||
| |
|||
| |
|||
|- |
|||
|[[Enterococcus species]] |
|||
|≤8 |
|||
| |
|||
|≥16 |
|||
|≥15 |
|||
| |
|||
|≤14 |
|||
|- |
|||
|[[Neisseria gonorrhoeae]] |
|||
|≤0.06 |
|||
|0.12-1 |
|||
|≥2 |
|||
|≥47 |
|||
|27-46 |
|||
|≤26 |
|||
|- |
|||
|[[Neisseria meningitidis]] |
|||
|≤0.06 |
|||
|0.12-0.25 |
|||
|≥0.5 |
|||
| |
|||
| |
|||
| |
|||
|- |
|||
|[[Staphylococcus species]] |
|||
|≤0.12 |
|||
| |
|||
|≥0.25 |
|||
|≥29 |
|||
| |
|||
|≤28 |
|||
|- |
|||
|[[Streptococcus pneumoniae]] |
|||
| |
|||
| |
|||
| |
|||
|≥20 |
|||
| |
|||
| |
|||
|- |
|||
|[[Streptococcus pneumoniae]] IV (nonmeningitis) |
|||
|≤2 |
|||
|4 |
|||
|≥8 |
|||
| |
|||
| |
|||
| |
|||
|- |
|||
|[[Streptococcus pneumoniae]] IV (meningitis) |
|||
|≤0.06 |
|||
| |
|||
|≥0.12 |
|||
| |
|||
| |
|||
| |
|||
|- |
|||
|[[Streptococcus pneumoniae]] PO (pen V) |
|||
|≤0.06 |
|||
|0.12-1 |
|||
|≥2 |
|||
| |
|||
| |
|||
| |
|||
|- |
|||
|[[Streptococcus species]] (β-hemolytic) |
|||
|≤0.12 |
|||
| |
|||
| |
|||
|≥24 |
|||
| |
|||
| |
|||
|- |
|||
|[[Streptococcus species]] (viridans group) |
|||
|≤0.12 |
|||
|0.25-2 |
|||
|≥4 |
|||
| |
|||
| |
|||
| |
|||
|} |
|||
[[Category:Beta-lactams]] |
[[Category:Beta-lactams]] |
Revision as of 15:19, 13 September 2020
Background
Nomenclature
- Broadly speaking, formulations of penicillin G are soluble and used for IV or IM administration, and penicillin V is used for oral administration but does not achieve high levels in the serum
Formulation | Other Names | Comments |
---|---|---|
sodium penicillin G | sodium benzylpenicillin
crystalline penicillin |
soluble, used for IV |
procaine penicillin G | procaine benzylpenicillin
procaine penicilli |
less soluble, used for IM |
benzathine penicillin G | DBED penicillin | less soluble than procaine, used for IM |
penicillin V | phenoxymethylpenicillin | used for PO, but poor absorption |
Mechanism of Action
- Directly inhibits penicillin-binding proteins
Spectrum of Activity
- Generally active against Gram-positive cocci, especially streptococci but some strains of Staphylococcus aureus, most clostridia, Neisseria species, and some Haemophilus influenzae
- Not active against aerobic Gram-negative bacilli
- Penicillin G is generally more active than penicillin V across all bacteria
Clinical Breakpoints
Species | Breakpoints (μg/mL) | Breakpoints (mm) | ||||
---|---|---|---|---|---|---|
S | I | R | S | I | R | |
Anaerobes except Bacteroides | ≤0.5 | 1 | ≥2 | |||
Enterococcus species | ≤8 | ≥16 | ≥15 | ≤14 | ||
Neisseria gonorrhoeae | ≤0.06 | 0.12-1 | ≥2 | ≥47 | 27-46 | ≤26 |
Neisseria meningitidis | ≤0.06 | 0.12-0.25 | ≥0.5 | |||
Staphylococcus species | ≤0.12 | ≥0.25 | ≥29 | ≤28 | ||
Streptococcus pneumoniae | ≥20 | |||||
Streptococcus pneumoniae IV (nonmeningitis) | ≤2 | 4 | ≥8 | |||
Streptococcus pneumoniae IV (meningitis) | ≤0.06 | ≥0.12 | ||||
Streptococcus pneumoniae PO (pen V) | ≤0.06 | 0.12-1 | ≥2 | |||
Streptococcus species (β-hemolytic) | ≤0.12 | ≥24 | ||||
Streptococcus species (viridans group) | ≤0.12 | 0.25-2 | ≥4 |